Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Efficacy and Safety of Anakinra in Acute Respiratory Distress Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the efficacy and safety of anakinra in Acute Respiratory Distress Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anakinra (anakinra)

Snippet

Sponsor: Azienda Sanitaria-Universitaria Integrata di Udine | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: UNKNOWN